GlaxoSmithKline plc (GSK) Earns Hold Rating from Deutsche Bank AG
Deutsche Bank AG reaffirmed their hold rating on shares of GlaxoSmithKline plc (LON:GSK) in a report issued on Wednesday morning, Marketbeat.com reports. Deutsche Bank AG currently has a GBX 1,610 ($21.71) target price on the stock.
Other equities research analysts have also issued reports about the company. Beaufort Securities upped their price objective on GlaxoSmithKline plc from GBX 1,750 ($23.59) to GBX 2,000 ($26.97) and gave the stock a buy rating in a research note on Thursday, June 1st. Bryan, Garnier & Co restated a buy rating and issued a GBX 1,750 ($23.59) price objective on shares of GlaxoSmithKline plc in a research note on Wednesday, May 31st. Liberum Capital restated a buy rating and issued a GBX 1,900 ($25.62) price objective on shares of GlaxoSmithKline plc in a research note on Wednesday, May 31st. HSBC Holdings plc restated a buy rating and issued a GBX 1,970 ($26.56) price objective on shares of GlaxoSmithKline plc in a research note on Wednesday, May 31st. Finally, Goldman Sachs Group, Inc. (The) restated a buy rating and issued a GBX 1,900 ($25.62) price objective on shares of GlaxoSmithKline plc in a research note on Wednesday, May 31st. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and seven have assigned a buy rating to the company’s stock. GlaxoSmithKline plc presently has an average rating of Hold and a consensus target price of GBX 1,698.52 ($22.90).
GlaxoSmithKline plc (LON GSK) opened at 1474.00 on Wednesday. GlaxoSmithKline plc has a 12-month low of GBX 1,444.00 and a 12-month high of GBX 1,745.56. The stock has a 50 day moving average price of GBX 1,503.38 and a 200-day moving average price of GBX 1,606.97. The company’s market capitalization is GBX 72.05 billion.
The firm also recently declared a dividend, which will be paid on Thursday, October 12th. Investors of record on Thursday, August 10th will be issued a GBX 19 ($0.26) dividend. This represents a dividend yield of 1.23%. The ex-dividend date is Thursday, August 10th.
In other news, insider Manvinder Singh Banga acquired 2,267 shares of GlaxoSmithKline plc stock in a transaction that occurred on Wednesday, July 26th. The shares were bought at an average cost of GBX 1,599 ($21.56) per share, with a total value of £36,249.33 ($48,873.30). Also, insider Patrick Vallance acquired 861 shares of GlaxoSmithKline plc stock in a transaction that occurred on Friday, July 14th. The stock was purchased at an average cost of GBX 1,618 ($21.81) per share, for a total transaction of £13,930.98 ($18,782.50). In the last ninety days, insiders purchased 3,152 shares of company stock valued at $5,055,023.
GlaxoSmithKline plc Company Profile
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.